<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
57520-1450-4
</NDCCode>
<PackageDescription>
3840 mL in 1 JUG (57520-1450-4)
</PackageDescription>
<NDC11Code>
57520-1450-04
</NDC11Code>
<ProductNDC>
57520-1450
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Epstein-barr Virus Nosode
</NonProprietaryName>
<DosageFormName>
LIQUID
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20211115
</StartMarketingDate>
<EndMarketingDate>
20281017
</EndMarketingDate>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Apotheca Company
</LabelerName>
<SubstanceName>
HUMAN HERPESVIRUS 4
</SubstanceName>
<StrengthNumber>
10
</StrengthNumber>
<StrengthUnit>
[hp_M]/mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2024-02-10
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
15-NOV-21
</StartMarketingDatePackage>
<EndMarketingDatePackage>
17-OCT-28
</EndMarketingDatePackage>
<SamplePackage/>
</NDC>